Young Model
Xerion is a specialty pharmaceutical company leveraging AMYCOT® — its proprietary platform technology — to resolve unmet medical needs in topical dermatological conditions ​

Xerion Limited was founded in May 2014 and is a public, unlisted specialty pharmaceutical company involved in the discovery, research and development, proof of concept, and commercialisation of bio-actives for use in human health, specifically dermatological conditions.


The Company is headquartered in Brighton, Victoria.

Xerion is focused on the commercialisation of algae-derived bio-active (AMYCOT®) in Prescription and Over the Counter (OTC) topical dermatological products as well as the research and development of new products.